Provided by Tiger Trade Technology Pte. Ltd.

Castle Biosciences, Inc.

23.53
-1.1700-4.74%
Post-market: 23.530.00000.00%18:46 EDT
Volume:294.10K
Turnover:7.01M
Market Cap:699.58M
PE:-28.23
High:24.65
Open:24.60
Low:23.44
Close:24.70
52wk High:44.28
52wk Low:14.59
Shares:29.73M
Float Shares:25.11M
Volume Ratio:0.97
T/O Rate:1.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8334
EPS(LYR):-0.8334
ROE:-5.21%
ROA:-2.56%
PB:1.49
PE(LYR):-28.23

Loading ...

Scibase and Castle Biosciences Expand Collaboration and License Agreement and Enter Into Loan Agreement of SEK 20 Million

THOMSON REUTERS
·
Nov 07, 2025

Scibase And Castle Biosciences Expand Collaboration

Reuters
·
Nov 07, 2025

SciBase Secures SEK 20 Million Loan from Castle Biosciences

Reuters
·
Nov 07, 2025

Stock Track | Castle Biosciences Soars 5.03% as BTIG Maintains Buy Rating

Stock Track
·
Nov 06, 2025

Castle Biosciences Navigates Regulatory Uncertainty Amid Shifting Policies and Trade Challenges

TIPRANKS
·
Nov 05, 2025

Castle Biosciences COO Kristen M. Oelschlager Reports Disposal of Common Shares

Reuters
·
Nov 05, 2025

Castle Biosciences Is Maintained at Outperform by Baird

Dow Jones
·
Nov 05, 2025

Stock Track | Castle Biosciences Soars 6% as Leerink Partners Boosts Price Target

Stock Track
·
Nov 04, 2025

U.S. RESEARCH ROUNDUP-Affiliated Managers Group, Argenx, Cardinal Health

Reuters
·
Nov 04, 2025

Castle Biosciences Inc : Leerink Partners Raises Target Price to $40 From $35

THOMSON REUTERS
·
Nov 04, 2025

Castle Biosciences Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
Nov 04, 2025

Castle Biosciences raises FY25 revenue view to $327M-$335M from $310M-$320M

TIPRANKS
·
Nov 04, 2025

Stock Track | Castle Biosciences Soars 5.48% on Strong Q3 Revenue Beat

Stock Track
·
Nov 04, 2025

BRIEF-Castle Biosciences Q3 Revenue USD 83.043 Million Vs. IBES Estimate USD 71.2 Million

Reuters
·
Nov 04, 2025

Castle Biosciences Q3 Pretax Profit USD -386 Thousand

THOMSON REUTERS
·
Nov 04, 2025

Castle Biosciences Inc - Raises Full-Year 2025 Revenue Guidance to $327-335 Million

THOMSON REUTERS
·
Nov 04, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 03, 2025

Castle Biosciences to Present at Stephens Annual Investment Conference

Reuters
·
Oct 28, 2025

Castle Biosciences announces new data on TissueCypher Barrett’s Esophagus test

TIPRANKS
·
Oct 27, 2025

BRIEF-Castle Biosciences Inc Says Tissuecypher® Provides Actionable Risk Insights That Influence Clinical Management And Prompt Risk-Aligned Intervention In Barrett’s Esophagus

Reuters
·
Oct 27, 2025